Blogs and News

Functional Service Provider (FSP) models can offer biotech and pharma companies more flexibility in the support they get from a CRO while putting them in control. But is it the right choice for your trial? And how can you get the most out of this approach? This blog post explores FSP and its benefits for clinical research.

SCOPE Europe offers an unparalleled opportunity to engage with thought leaders, explore cutting-edge technologies, and network with industry experts. Over the course of two days, attendees will participate in keynote sessions, interactive breakouts, and panel discussions, all while gaining insights into the latest trends in digital and hybrid trials.

Artificial intelligence (AI) promises efficiency, accuracy, and cost savings, but what can it actually deliver when it comes to clinical trials? Whether you’re in the design process of your clinical trial, working on regulatory submissions, recruiting participants, or collecting and analyzing data, there may be AI tools to help.

If you’re looking for the right CRO for your clinical trial, you’re likely considering many factors, including expertise, prior success, budget… but what’s size got to do with it? More than you might think. In this blog post, we look at the benefits of partnering with a smaller CRO.

Used in the right way, decentralization can help put patients at the heart of a clinical trial. But if a fully decentralized or hybrid trial is designed and implemented without considering participants’ perspectives, it can result in gaps in data, low participant retention and delays.

This has been a year of change in the clinical trials landscape, with developments in regulation and the evolution of technology driving the move toward more patient centricity. Here we look at some of the highlights.

Choosing a partner to support your clinical trial is a big decision, and understanding what your collaboration might look like can help. After more than two decades of working with a multitude of clients, Siron Clinical has perfected the process from RFP and trial...

In the fast-moving field of clinical trials, it can be challenging to keep up-to-date with the latest news, views, and changes. But with new regulation frequently appearing around the world and technological innovation changing...

Now nearing the end of their second year in use, the EU’s Clinical Trial Regulation and its associated Clinical Trials Information System (CTIS) have meant some big changes for sponsors and others involved in designing, getting...

Small biotech companies are responsible for a significant proportion of newly approved medicines, especially for rare diseases. But with limited resources, budget constraints and a lean structure, they face many challenges before...